Status:
RECRUITING
Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Migraine, Greater Occipital Nerve Pulsed Radiofrequency
Headache Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study is designed to compare the clinical effectiveness of unilateral and bilateral Greater Occipital Nerve Pulsed Radiofrequency (GON-PRF) treatment at the C2 level in patients with migraine. Th...
Detailed Description
Migraine is a common neurological disorder that can affect patients' quality of life and socio-economic functionality. In cases of resistant headaches that do not respond to conservative pharmacologic...
Eligibility Criteria
Inclusion
- Volunteers who are followed up at the Algology polyclinic of Ankara Bilkent City Hospital, between the ages of 18-65, who meet the diagnosis criteria for episodic (≥5 attacks/month) or chronic migraine according to ICHD-3 criteria, who do not benefit sufficiently from the migraine prevention medications used, who are not currently using migraine prevention medications or who have not changed their medication and/or dosage in the last 3 months, who do not have bleeding-clotting disorders and active infection in laboratory tests, who are not pregnant or suspected of being pregnant, who do not have a history of craniocervical surgery that may disrupt the anatomical structure in the intervention area, who can understand and approve the treatment and the informed consent form and who can comply with the treatment will be included in this study. Exclusion criteria for files/records/materials to be included in the study: Patients with a history of primary headache other than migraine according to ICHD-3 criteria, \<5 attacks per month, comorbid diseases that may cause headaches (such as uncontrolled hypertension, intracranial lesions), and those who have received interventional treatment, botulinum toxin injection and/or non-pharmacological treatment (acupuncture, physical therapy, ozone, cognitive behavioral therapy, etc.) for migraine within 3 months prior to GON-PRF treatment will not be included in the study.
- \-
Exclusion
- The voluntary participants' request to withdraw for any reason at any stage of the study, the volunteer/legal representative's withdrawal of consent to participate in the study, failure to attend follow-up, and the emergence of any of the following criteria for not being included in the study.
- \-
Key Trial Info
Start Date :
December 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT06894121
Start Date
December 18 2024
End Date
January 1 2026
Last Update
March 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences University, Ankara Bilkent City Hospital
Ankara, Cankaya, Turkey (Türkiye), 06800
2
Health Sciences University, Ankara Bilkent City Hospital
Ankara, Cankaya, Turkey (Türkiye), 06800